US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nuvectis Pharma, Inc.

8.46

-0.0500-0.59%

Post-market: 8.460.00000.00%16:04 EST

Volume:43.16K

Turnover:363.65K

Market Cap:224.12M

PE:-6.39

High:8.56

Open:8.45

Low:8.26

Close:8.51

52wk High:11.52

52wk Low:5.55

Shares:26.49M

Float Shares:14.54M

Volume Ratio:0.79

T/O Rate:0.30%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.3236

EPS(LYR):-1.3236

ROE:-188.03%

ROA:-68.50%

PB:12.17

PE(LYR):-6.39

Loading ...

Overview Company News Filings

Nuvectis Pharma Files $150 Million Mixed Shelf

MT Newswires Live

Nuvectis Pharma files $150M mixed securities shelf

Nuvectis Pharma Inc : Files for Mixed Shelf Offering of up to $150 Mln - SEC Filing

THOMSON REUTERS

Nuvectis Pharma Q4 EPS $(0.31), Inline

Nuvectis Pharma Inc. FY25 net loss attributable to common shareholders widens to USD 28.87 million, up 52%

Nuvectis Pharma, Inc. Reports 2025 Financial Results and Business Highlights

Nuvectis Pharma Announces the Initiation of the Phase 1B Study of Nxp900 in Combination With Osimertinib in Patients With Nsclc

THOMSON REUTERS

Nuvectis Pharma Announces the Initiation of the Phase 1b Study of NXP900 in Combination with Osimertinib in Patients with NSCLC

Nuvectis Pharma Hosts Virtual Meeting on NXP900 Phase 1b Program in Advanced Solid Tumors

Buy Rating for Nuvectis Pharma’s NXP900 Driven by Promising Efficacy and Development Progress

Nuvectis Pharma Executives Make Bold Moves with Major Stock Purchases!

Director Matthew L. Kaplan Acquires Common Shares of Nuvectis Pharma Inc

Maxim Group Reaffirms Their Buy Rating on Nuvectis Pharma (NVCT)

Nuvectis Pharma Reports Progress in Oncology Drug Development

Analysts Offer Insights on Healthcare Companies: Alpha Teknova (TKNO) and Nuvectis Pharma (NVCT)

Nuvectis Pharma Q3 EPS $(0.44) Misses $(0.25) Estimate

BRIEF-Nuvectis Pharma Q3 EPS USD -0.44

Nuvectis Pharma Q3 net loss widens

Nuvectis Pharma Inc: Cash Runway Expected to Support Company's Operations Into 3Q-2027

THOMSON REUTERS

Nuvectis Pharma reports third quarter net loss of $7.5 million

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/NVCT/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NVCT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVCT\",,,,,undefined,":{"symbol":"NVCT","market":"US","secType":"STK","nameCN":"Nuvectis Pharma, Inc.","latestPrice":8.46,"timestamp":1771621200000,"preClose":8.51,"halted":0,"volume":43162,"hourTrading":{"tag":"盘后","latestPrice":8.46,"preClose":8.46,"latestTime":"16:04 EST","volume":555,"amount":4695.3,"timestamp":1771621485704,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.005875440658049229,"floatShares":14536600,"shares":26491700,"eps":-1.323585,"marketStatus":"Market Closed","change":-0.05,"latestTime":"02-20 16:00:00 EST","open":8.45,"high":8.56,"low":8.255,"amount":363654.3504,"amplitude":0.03584,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.323585,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":7,"adr":0,"listingDate":1638334800000,"exchange":"NASDAQ","adjPreClose":8.51,"postHourTrading":{"tag":"盘后","latestPrice":8.46,"preClose":8.46,"latestTime":"16:04 EST","volume":555,"amount":4695.3,"timestamp":1771621485704,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7891282330250455,"impliedVol":0.4099,"impliedVolPercentile":0.1275},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVCT\",,,,,undefined,":{"symbol":"NVCT","floatShares":14536600,"roa":"-68.50%","roe":"-188.03%","lyrEps":-1.323585,"volumeRatio":0.7891282330250455,"shares":26491700,"dividePrice":0,"high":8.56,"amplitude":0.03584,"preClose":8.51,"low":8.255,"week52Low":5.55,"pbRate":"12.17","week52High":11.52,"institutionHeld":0,"latestPrice":8.46,"eps":-1.323585,"divideRate":0,"volume":43162,"delay":0,"ttmEps":-1.323585,"open":8.45,"prevYearClose":7.55,"prevWeekClose":8.76,"prevMonthClose":8.11,"prevQuarterClose":7.55,"fiveDayClose":8.8,"twentyDayClose":8.76,"sixtyDayClose":6.08},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVCT\",params:#limit:5,,,undefined,":[{"date":"2026-02-11","symbol":"NVCT","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770800400000,"name":null,"time":"Pre-Market","dateTimestamp":1770786000000,"actualEps":null},{"market":"US","date":"2025-11-04","symbol":"NVCT","fiscalQuarterEnding":"2025/09","expectedEps":-0.24,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"pre","actualEps":-0.44},{"market":"US","date":"2025-08-05","symbol":"NVCT","fiscalQuarterEnding":"2025/06","expectedEps":-0.25,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"pre","actualEps":-0.3},{"market":"US","date":"2025-05-06","symbol":"NVCT","fiscalQuarterEnding":"2025/03","expectedEps":-0.3,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746504000000,"reportTimeType":"pre","actualEps":-0.27},{"market":"US","date":"2025-02-25","symbol":"NVCT","fiscalQuarterEnding":"2024/12","expectedEps":-0.28,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740459600000,"reportTimeType":"pre","actualEps":-0.36}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVCT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVCT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1667,"buy":0.8333,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8333,"analysts":6,"updateTime":1743570000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NVCT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NVCT","date":"2026-02-19","current":-6.391732,"percent":0.423038,"low":-4822.163542,"twenty":-11.035063,"median":-7.849906,"eighty":-6.152344,"high":-4.507629,"avg":-128.176852,"sd":653.417061,"marketCap":228623388},"quantilePoints":[{"date":"2022-02-04","current":-1722.20125,"twenty":-2416.901458,"median":-2416.901458,"eighty":-2000.081333,"marketCap":41332830},{"date":"2022-02-11","current":-3677.562083,"twenty":-3582.178633,"median":-3306.626438,"eighty":-2416.901458,"marketCap":88261490},{"date":"2022-02-18","current":-3105.261333,"twenty":-3521.769108,"median":-3195.345708,"eighty":-2596.861958,"marketCap":74526272},{"date":"2022-02-25","current":-3359.617208,"twenty":-3425.325841,"median":-3227.140208,"eighty":-2883.759766,"marketCap":80630813},{"date":"2022-03-04","current":-3990.207833,"twenty":-3634.109608,"median":-3354.318146,"eighty":-2982.322667,"marketCap":95764988},{"date":"2022-03-11","current":-4382.339833,"twenty":-4096.189467,"median":-3439.103458,"eighty":-3123.278208,"marketCap":105176156},{"date":"2022-03-18","current":-4149.180292,"twenty":-4143.881209,"median":-3592.776792,"eighty":-3195.345708,"marketCap":99580327},{"date":"2022-03-25","current":-7.409669,"twenty":-4111.026892,"median":-3439.103458,"eighty":-2883.759766,"marketCap":95510632},{"date":"2022-04-01","current":-6.926215,"twenty":-4060.1557,"median":-3354.318146,"eighty":-350.415344,"marketCap":89278913},{"date":"2022-04-08","current":-9.323751,"twenty":-4037.899584,"median":-3227.140208,"eighty":-8.266073,"marketCap":120183153},{"date":"2022-04-14","current":-9.965067,"twenty":-4016.70325,"median":-3195.345708,"eighty":-8.337111,"marketCap":128449719},{"date":"2022-04-22","current":-9.550678,"twenty":-3990.207833,"median":-3028.424667,"eighty":-9.234954,"marketCap":123108245},{"date":"2022-04-29","current":-9.373083,"twenty":-3905.422542,"median":-2416.901458,"eighty":-9.234954,"marketCap":120819043},{"date":"2022-05-06","current":-17.956854,"twenty":-3677.562083,"median":-870.079052,"eighty":-9.234954,"marketCap":231463850},{"date":"2022-05-13","current":-15.163214,"twenty":-3640.4685,"median":-14.858803,"eighty":-9.323751,"marketCap":239730416},{"date":"2022-05-20","current":-12.468425,"twenty":-3608.674042,"median":-15.011008,"eighty":-9.373083,"marketCap":197125807},{"date":"2022-05-27","current":-12.597132,"twenty":-3576.879542,"median":-14.366844,"eighty":-9.373083,"marketCap":199160654},{"date":"2022-06-03","current":-9.773637,"twenty":-3517.529842,"median":-13.793232,"eighty":-9.396762,"marketCap":154521197},{"date":"2022-06-10","current":-9.652975,"twenty":-3451.82125,"median":-12.774103,"eighty":-9.410576,"marketCap":152613528},{"date":"2022-06-17","current":-8.824428,"twenty":-3383.992992,"median":-12.70975,"eighty":-9.363217,"marketCap":139514200},{"date":"2022-06-24","current":-9.242723,"twenty":-3363.856475,"median":-12.468425,"eighty":-9.239615,"marketCap":146127453},{"date":"2022-07-01","current":-9.64493,"twenty":-3353.258333,"median":-11.474627,"eighty":-9.239615,"marketCap":152486350},{"date":"2022-07-08","current":-10.224109,"twenty":-3315.104967,"median":-10.465433,"eighty":-9.275134,"marketCap":161643161},{"date":"2022-07-15","current":-9.086265,"twenty":-3249.396358,"median":-10.409124,"eighty":-9.258683,"marketCap":143653842},{"date":"2022-07-22","current":-9.586449,"twenty":-3214.422408,"median":-10.216065,"eighty":-9.238062,"marketCap":151561766},{"date":"2022-07-29","current":-7.078848,"twenty":-3195.345708,"median":-9.9848,"eighty":-9.113213,"marketCap":111916587},{"date":"2022-08-05","current":-8.052111,"twenty":-3195.345708,"median":-9.910387,"eighty":-8.975658,"marketCap":108228426},{"date":"2022-08-12","current":-9.488582,"twenty":-3159.311958,"median":-9.805813,"eighty":-8.932791,"marketCap":127536026},{"date":"2022-08-19","current":-9.793611,"twenty":-3043.792,"median":-9.810606,"eighty":-8.975658,"marketCap":131635922},{"date":"2022-08-26","current":-9.510369,"twenty":-2917.673883,"median":-9.781681,"eighty":-9.015878,"marketCap":127828876},{"date":"2022-09-02","current":-9.031038,"twenty":-2686.842208,"median":-9.757814,"eighty":-8.975658,"marketCap":121386184},{"date":"2022-09-09","current":-9.150871,"twenty":-2416.901458,"median":-9.745482,"eighty":-8.964396,"marketCap":122996857},{"date":"2022-09-16","current":-8.932993,"twenty":-2277.961416,"median":-9.701239,"eighty":-8.937021,"marketCap":120068360},{"date":"2022-09-23","current":-8.573495,"twenty":-1381.352371,"median":-9.632337,"eighty":-8.826532,"marketCap":115236341},{"date":"2022-09-30","current":-7.723771,"twenty":-17.65393,"median":-9.586518,"eighty":-8.651931,"marketCap":103815204},{"date":"2022-10-07","current":-7.63662,"twenty":-16.210562,"median":-9.563205,"eighty":-8.405729,"marketCap":102643805},{"date":"2022-10-14","current":-7.603938,"twenty":-15.261352,"median":-9.524268,"eighty":-8.26218,"marketCap":102204531},{"date":"2022-10-21","current":-7.680195,"twenty":-15.169649,"median":-9.483135,"eighty":-8.073594,"marketCap":103229505},{"date":"2022-10-28","current":-7.810268,"twenty":-15.102332,"median":-9.471747,"eighty":-7.885,"marketCap":104977817},{"date":"2022-11-04","current":-7.576703,"twenty":-14.768455,"median":-9.451943,"eighty":-7.747738,"marketCap":101838469},{"date":"2022-11-11","current":-6.796511,"twenty":-14.399021,"median":-9.402682,"eighty":-7.680195,"marketCap":99568884},{"date":"2022-11-18","current":-7.224291,"twenty":-14.29948,"median":-9.348417,"eighty":-7.640977,"marketCap":105835867},{"date":"2022-11-25","current":-7.26627,"twenty":-14.030026,"median":-9.293004,"eighty":-7.625726,"marketCap":106450851},{"date":"2022-12-02","current":-7.506147,"twenty":-13.793232,"median":-9.25981,"eighty":-7.576703,"marketCap":109965047},{"date":"2022-12-09","current":-7.506147,"twenty":-12.999339,"median":-9.210288,"eighty":-7.516141,"marketCap":109965047},{"date":"2022-12-16","current":-7.406198,"twenty":-12.782147,"median":-9.150762,"eighty":-7.496152,"marketCap":108500799},{"date":"2022-12-23","current":-7.738527,"twenty":-12.766059,"median":-9.1187,"eighty":-7.454973,"marketCap":113369424},{"date":"2022-12-30","current":-7.496152,"twenty":-12.766059,"median":-9.099176,"eighty":-7.44634,"marketCap":109818622},{"date":"2023-01-06","current":-7.594801,"twenty":-12.732274,"median":-9.091333,"eighty":-7.450405,"marketCap":111263835},{"date":"2023-01-13","current":-7.406198,"twenty":-12.642179,"median":-9.041932,"eighty":-7.450257,"marketCap":108500799},{"date":"2023-01-20","current":-7.496152,"twenty":-12.545649,"median":-9.025531,"eighty":-7.451274,"marketCap":109818622},{"date":"2023-01-27","current":-7.975905,"twenty":-12.317195,"median":-8.981288,"eighty":-7.451274,"marketCap":116847014},{"date":"2023-02-03","current":-10.369677,"twenty":-11.855901,"median":-9.025531,"eighty":-7.452843,"marketCap":151915761},{"date":"2023-02-10","current":-14.362627,"twenty":-11.979785,"median":-9.058273,"eighty":-7.455453,"marketCap":210412480},{"date":"2023-02-17","current":-9.964884,"twenty":-11.831926,"median":-9.096402,"eighty":-7.46125,"marketCap":145985555},{"date":"2023-02-24","current":-10.434643,"twenty":-11.751993,"median":-9.101951,"eighty":-7.472325,"marketCap":152867522},{"date":"2023-03-03","current":-11.973853,"twenty":-11.789947,"median":-9.134127,"eighty":-7.486157,"marketCap":175416946},{"date":"2023-03-10","current":-8.326972,"twenty":-11.789947,"median":-9.107295,"eighty":-7.488136,"marketCap":158920261},{"date":"2023-03-17","current":-9.237161,"twenty":-11.658015,"median":-9.099176,"eighty":-7.496072,"marketCap":176291215},{"date":"2023-03-24","current":-9.086429,"twenty":-11.512116,"median":-9.107295,"eighty":-7.496152,"marketCap":173414497},{"date":"2023-03-31","current":-10.133823,"twenty":-11.492386,"median":-9.134127,"eighty":-7.496152,"marketCap":193404003},{"date":"2023-04-06","current":-9.75506,"twenty":-11.456868,"median":-9.150762,"eighty":-7.496152,"marketCap":186175325},{"date":"2023-04-14","current":-11.478815,"twenty":-11.451785,"median":-9.210288,"eighty":-7.496152,"marketCap":219073184},{"date":"2023-04-21","current":-10.705831,"twenty":-11.440849,"median":-9.236058,"eighty":-7.496152,"marketCap":204320781},{"date":"2023-04-28","current":-11.463355,"twenty":-11.463355,"median":-9.251266,"eighty":-7.496152,"marketCap":218778136},{"date":"2023-05-01","current":-12.211645,"twenty":-11.469477,"median":-9.25981,"eighty":-7.496152,"marketCap":233059240},{"date":"2023-05-12","current":-11.89369,"twenty":-11.658015,"median":-9.26808,"eighty":-7.496152,"marketCap":240145501},{"date":"2023-05-19","current":-13.141553,"twenty":-11.893853,"median":-9.303385,"eighty":-7.4981,"marketCap":265341095},{"date":"2023-05-26","current":-13.572736,"twenty":-12.376667,"median":-9.373083,"eighty":-7.505944,"marketCap":274047116},{"date":"2023-06-02","current":-13.905712,"twenty":-12.463106,"median":-9.391925,"eighty":-7.506147,"marketCap":280770234},{"date":"2023-06-09","current":-13.897784,"twenty":-12.70975,"median":-9.412549,"eighty":-7.506147,"marketCap":280610160},{"date":"2023-06-16","current":-14.42896,"twenty":-12.999339,"median":-9.452014,"eighty":-7.506147,"marketCap":291335135},{"date":"2023-06-23","current":-14.056344,"twenty":-13.239822,"median":-9.471747,"eighty":-7.514142,"marketCap":283811645},{"date":"2023-06-30","current":-12.954352,"twenty":-13.244502,"median":-9.481102,"eighty":-7.534132,"marketCap":261561324},{"date":"2023-07-07","current":-12.034704,"twenty":-13.213305,"median":-9.499475,"eighty":-7.55812,"marketCap":242992711},{"date":"2023-07-14","current":-12.082272,"twenty":-13.164951,"median":-9.548401,"eighty":-7.576348,"marketCap":243953157},{"date":"2023-07-21","current":-11.321184,"twenty":-13.104727,"median":-9.564908,"eighty":-7.580464,"marketCap":228586029},{"date":"2023-07-28","current":-11.154696,"twenty":-13.046317,"median":-9.586518,"eighty":-7.586105,"marketCap":225224469},{"date":"2023-08-04","current":-11.4956,"twenty":-13.024672,"median":-9.61481,"eighty":-7.589583,"marketCap":232107662},{"date":"2023-08-11","current":-11.568146,"twenty":-12.981344,"median":-9.64493,"eighty":-7.595321,"marketCap":258316695},{"date":"2023-08-18","current":-11.190253,"twenty":-12.938496,"median":-9.709283,"eighty":-7.5961,"marketCap":249878349},{"date":"2023-08-25","current":-11.167117,"twenty":-12.914712,"median":-9.749504,"eighty":-7.599235,"marketCap":249361716},{"date":"2023-09-01","current":-11.036011,"twenty":-12.870315,"median":-9.760327,"eighty":-7.612653,"marketCap":246434127},{"date":"2023-09-08","current":-11.151692,"twenty":-12.799405,"median":-9.777659,"eighty":-7.625726,"marketCap":249017293},{"date":"2023-09-15","current":-10.81236,"twenty":-12.778929,"median":-9.805813,"eighty":-7.625726,"marketCap":241440004},{"date":"2023-09-22","current":-10.550149,"twenty":-12.766059,"median":-9.8581,"eighty":-7.627797,"marketCap":235584825},{"date":"2023-09-29","current":-10.642694,"twenty":-12.754797,"median":-9.91491,"eighty":-7.636188,"marketCap":237651359},{"date":"2023-10-06","current":-8.38305,"twenty":-12.687226,"median":-9.900583,"eighty":-7.63662,"marketCap":187193498},{"date":"2023-10-13","current":-7.380477,"twenty":-12.582954,"median":-9.815398,"eighty":-7.63662,"marketCap":164806051},{"date":"2023-10-20","current":-6.994872,"twenty":-12.517778,"median":-9.787646,"eighty":-7.625726,"marketCap":156195494},{"date":"2023-10-27","current":-6.856054,"twenty":-12.500855,"median":-9.777659,"eighty":-7.617011,"marketCap":153095694},{"date":"2023-11-03","current":-7.295644,"twenty":-12.474627,"median":-9.75506,"eighty":-7.591323,"marketCap":162911728},{"date":"2023-11-10","current":-6.384789,"twenty":-12.465234,"median":-9.745482,"eighty":-7.564117,"marketCap":142597868},{"date":"2023-11-17","current":-6.361515,"twenty":-12.460749,"median":-9.701239,"eighty":-7.506147,"marketCap":142078070},{"date":"2023-11-24","current":-6.361515,"twenty":-12.450927,"median":-9.64493,"eighty":-7.496152,"marketCap":142078070},{"date":"2023-12-01","current":-6.594253,"twenty":-12.430299,"median":-9.61481,"eighty":-7.496152,"marketCap":147276049},{"date":"2023-12-08","current":-6.547705,"twenty":-12.335412,"median":-9.586518,"eighty":-7.486157,"marketCap":146236453},{"date":"2023-12-15","current":-6.625285,"twenty":-12.194779,"median":-9.564908,"eighty":-7.452843,"marketCap":147969112},{"date":"2023-12-22","current":-6.260661,"twenty":-12.140939,"median":-9.548401,"eighty":-7.432254,"marketCap":139825613},{"date":"2023-12-29","current":-6.648559,"twenty":-12.098128,"median":-9.517319,"eighty":-7.416193,"marketCap":148488910},{"date":"2024-01-05","current":-6.4934,"twenty":-12.093462,"median":-9.488582,"eighty":-7.408281,"marketCap":145023591},{"date":"2024-01-12","current":-7.54848,"twenty":-12.085504,"median":-9.474718,"eighty":-7.408281,"marketCap":168587759},{"date":"2024-01-19","current":-6.439094,"twenty":-12.082272,"median":-9.46188,"eighty":-7.391646,"marketCap":143810730},{"date":"2024-01-26","current":-5.996891,"twenty":-12.063245,"median":-9.451871,"eighty":-7.358883,"marketCap":133934571},{"date":"2024-02-02","current":-5.539173,"twenty":-12.010364,"median":-9.403927,"eighty":-7.324002,"marketCap":123711881},{"date":"2024-02-09","current":-5.345224,"twenty":-11.96331,"median":-9.373083,"eighty":-7.303747,"marketCap":119380232},{"date":"2024-02-16","current":-6.105503,"twenty":-11.93164,"median":-9.313568,"eighty":-7.27802,"marketCap":136360294},{"date":"2024-02-23","current":-5.787427,"twenty":-11.905064,"median":-9.279216,"eighty":-7.226222,"marketCap":129256391},{"date":"2024-03-01","current":-7.657092,"twenty":-11.893853,"median":-9.25981,"eighty":-7.201903,"marketCap":171013482},{"date":"2024-03-08","current":-8.110119,"twenty":-11.888595,"median":-9.239942,"eighty":-7.226222,"marketCap":180531251},{"date":"2024-03-15","current":-7.303897,"twenty":-11.863459,"median":-9.185622,"eighty":-7.234415,"marketCap":162584739},{"date":"2024-03-22","current":-7.224073,"twenty":-11.84433,"median":-9.144455,"eighty":-7.224117,"marketCap":160807857},{"date":"2024-03-28","current":-6.657322,"twenty":-11.84392,"median":-9.1187,"eighty":-7.196306,"marketCap":148191992},{"date":"2024-04-05","current":-6.154431,"twenty":-11.813935,"median":-9.096402,"eighty":-7.141402,"marketCap":136997633},{"date":"2024-04-12","current":-5.922941,"twenty":-11.807221,"median":-9.086347,"eighty":-7.106352,"marketCap":131844674},{"date":"2024-04-19","current":-5.364173,"twenty":-11.73344,"median":-9.082564,"eighty":-7.087417,"marketCap":119406497},{"date":"2024-04-26","current":-5.196543,"twenty":-11.725512,"median":-9.036485,"eighty":-7.056377,"marketCap":115675044},{"date":"2024-05-03","current":-5.5789,"twenty":-11.693997,"median":-9.020144,"eighty":-6.994872,"marketCap":124186324},{"date":"2024-05-10","current":-5.232404,"twenty":-11.670016,"median":-8.943064,"eighty":-6.926009,"marketCap":117111662},{"date":"2024-05-17","current":-5.355423,"twenty":-11.568146,"median":-8.86763,"eighty":-6.867017,"marketCap":119865071},{"date":"2024-05-24","current":-5.478442,"twenty":-11.551096,"median":-8.824241,"eighty":-6.807818,"marketCap":122618480},{"date":"2024-05-31","current":-5.248806,"twenty":-11.540057,"median":-8.78056,"eighty":-6.750346,"marketCap":117478784},{"date":"2024-06-07","current":-5.355423,"twenty":-11.535651,"median":-8.71467,"eighty":-6.643904,"marketCap":119865071},{"date":"2024-06-14","current":-5.601461,"twenty":-11.522593,"median":-8.700328,"eighty":-6.585481,"marketCap":125371889},{"date":"2024-06-21","current":-5.601461,"twenty":-11.514132,"median":-8.595282,"eighty":-6.550808,"marketCap":125371889},{"date":"2024-06-28","current":-5.14219,"twenty":-11.514103,"median":-8.591276,"eighty":-6.544445,"marketCap":115092496},{"date":"2024-07-05","current":-5.084781,"twenty":-11.509505,"median":-8.549205,"eighty":-6.524432,"marketCap":113807572},{"date":"2024-07-12","current":-5.248806,"twenty":-11.505115,"median":-8.477607,"eighty":-6.501158,"marketCap":117478784},{"date":"2024-07-15","current":-5.396429,"twenty":-11.504671,"median":-8.471907,"eighty":-6.499606,"marketCap":120782874},{"date":"2024-08-02","current":-5.068379,"twenty":-11.504226,"median":-8.439046,"eighty":-6.4934,"marketCap":113440450},{"date":"2024-08-09","current":-6.04608,"twenty":-11.4956,"median":-8.380128,"eighty":-6.446852,"marketCap":127584385},{"date":"2024-08-16","current":-5.568758,"twenty":-11.4956,"median":-8.33936,"eighty":-6.431336,"marketCap":117511934},{"date":"2024-08-23","current":-6.364295,"twenty":-11.487672,"median":-8.317646,"eighty":-6.400304,"marketCap":134299353},{"date":"2024-08-30","current":-6.001884,"twenty":-11.478815,"median":-8.282792,"eighty":-6.361515,"marketCap":126651751},{"date":"2024-09-06","current":-5.445008,"twenty":-11.472569,"median":-8.234715,"eighty":-6.361515,"marketCap":114900558},{"date":"2024-09-13","current":-5.745544,"twenty":-11.464886,"median":-8.172852,"eighty":-6.350611,"marketCap":121242472},{"date":"2024-09-20","current":-5.966527,"twenty":-11.457439,"median":-8.106128,"eighty":-6.299451,"marketCap":125905644},{"date":"2024-09-27","current":-5.445008,"twenty":-11.447214,"median":-8.0288,"eighty":-6.249174,"marketCap":114900558},{"date":"2024-10-04","current":-5.445008,"twenty":-11.428314,"median":-7.993998,"eighty":-6.196292,"marketCap":114900558},{"date":"2024-10-11","current":-5.471526,"twenty":-11.41595,"median":-7.975905,"eighty":-6.137667,"marketCap":115460138},{"date":"2024-10-18","current":-5.975366,"twenty":-11.389225,"median":-7.92057,"eighty":-6.076134,"marketCap":126092170},{"date":"2024-10-25","current":-7.734386,"twenty":-11.342169,"median":-7.870838,"eighty":-6.088277,"marketCap":163211020},{"date":"2024-10-31","current":-6.974207,"twenty":-11.32549,"median":-7.854682,"eighty":-6.099297,"marketCap":147169708},{"date":"2024-11-08","current":-8.029494,"twenty":-11.299815,"median":-7.828418,"eighty":-6.086567,"marketCap":155563417},{"date":"2024-11-15","current":-5.516667,"twenty":-11.283906,"median":-7.854682,"eighty":-6.086567,"marketCap":106879902},{"date":"2024-11-22","current":-4.886589,"twenty":-11.259662,"median":-7.803133,"eighty":-6.007187,"marketCap":94672767},{"date":"2024-11-29","current":-5.026205,"twenty":-11.229851,"median":-7.772793,"eighty":-5.982437,"marketCap":97377703},{"date":"2024-12-06","current":-4.746972,"twenty":-11.207233,"median":-7.743226,"eighty":-5.930799,"marketCap":91967831},{"date":"2024-12-13","current":-4.6273,"twenty":-11.199507,"median":-7.732114,"eighty":-5.891293,"marketCap":89649314},{"date":"2024-12-20","current":-4.677163,"twenty":-11.187168,"median":-7.695034,"eighty":-5.858687,"marketCap":90615363},{"date":"2024-12-27","current":-5.00626,"twenty":-11.179456,"median":-7.680195,"eighty":-5.833974,"marketCap":96991284},{"date":"2025-01-03","current":-5.375247,"twenty":-11.167117,"median":-7.680195,"eighty":-5.765486,"marketCap":104140044},{"date":"2025-01-10","current":-6.153113,"twenty":-11.15718,"median":-7.674115,"eighty":-5.765219,"marketCap":119210403},{"date":"2025-01-17","current":-5.445056,"twenty":-11.152293,"median":-7.657092,"eighty":-5.745544,"marketCap":105492512},{"date":"2025-01-24","current":-6.402428,"twenty":-11.143981,"median":-7.63662,"eighty":-5.743678,"marketCap":124040646},{"date":"2025-01-31","current":-6.721552,"twenty":-11.137297,"median":-7.62606,"eighty":-5.745544,"marketCap":130223358},{"date":"2025-02-07","current":-8.933023,"twenty":-11.094623,"median":-7.625726,"eighty":-5.756709,"marketCap":173068391},{"date":"2025-02-14","current":-8.575209,"twenty":-11.04835,"median":-7.63608,"eighty":-5.764953,"marketCap":166136094},{"date":"2025-02-21","current":-9.278499,"twenty":-11.027345,"median":-7.63662,"eighty":-5.774262,"marketCap":179761644},{"date":"2025-02-28","current":-8.442054,"twenty":-11.010673,"median":-7.657749,"eighty":-5.790095,"marketCap":160399020},{"date":"2025-03-07","current":-7.571459,"twenty":-11.00084,"median":-7.658407,"eighty":-5.794098,"marketCap":143857718},{"date":"2025-03-14","current":-10.279948,"twenty":-10.991897,"median":-7.680195,"eighty":-5.810034,"marketCap":195319016},{"date":"2025-03-21","current":-11.51108,"twenty":-11.024301,"median":-7.680195,"eighty":-5.833952,"marketCap":218710515},{"date":"2025-03-28","current":-11.880419,"twenty":-11.05452,"median":-7.709402,"eighty":-5.833974,"marketCap":225727965},{"date":"2025-04-04","current":-11.14174,"twenty":-11.147711,"median":-7.734386,"eighty":-5.837495,"marketCap":211693065},{"date":"2025-04-11","current":-10.495396,"twenty":-11.14058,"median":-7.744393,"eighty":-5.846312,"marketCap":199412528},{"date":"2025-04-17","current":-10.710844,"twenty":-11.149702,"median":-7.758662,"eighty":-5.855152,"marketCap":203506041},{"date":"2025-04-25","current":-13.493202,"twenty":-11.164633,"median":-7.795998,"eighty":-5.871062,"marketCap":256370829},{"date":"2025-05-02","current":-11.843485,"twenty":-11.207752,"median":-7.810247,"eighty":-5.879113,"marketCap":225026220},{"date":"2025-05-09","current":-10.697367,"twenty":-11.237045,"median":-7.846568,"eighty":-5.884079,"marketCap":215669620},{"date":"2025-05-16","current":-10.878873,"twenty":-11.207752,"median":-7.868697,"eighty":-5.889786,"marketCap":219328958},{"date":"2025-05-23","current":-11.664309,"twenty":-11.314061,"median":-7.913104,"eighty":-5.895991,"marketCap":235164130},{"date":"2025-05-30","current":-10.960933,"twenty":-11.324344,"median":-7.941649,"eighty":-5.896706,"marketCap":220983379},{"date":"2025-06-06","current":-10.515462,"twenty":-11.324344,"median":-7.987178,"eighty":-5.92233,"marketCap":212002236},{"date":"2025-06-13","current":-10.351341,"twenty":-11.321184,"median":-8.017247,"eighty":-5.922941,"marketCap":208693394},{"date":"2025-06-20","current":-9.436953,"twenty":-11.292692,"median":-8.029494,"eighty":-5.938657,"marketCap":190258417},{"date":"2025-06-27","current":-9.038374,"twenty":-11.283352,"median":-8.106128,"eighty":-5.948792,"marketCap":182222658},{"date":"2025-07-03","current":-8.839084,"twenty":-11.259662,"median":-8.16619,"eighty":-5.960054,"marketCap":178204778},{"date":"2025-07-11","current":-12.134732,"twenty":-11.299815,"median":-8.221117,"eighty":-5.97183,"marketCap":244648338},{"date":"2025-07-18","current":-11.779136,"twenty":-11.352391,"median":-8.261696,"eighty":-5.985973,"marketCap":237479156},{"date":"2025-07-25","current":-11.453172,"twenty":-11.417996,"median":-8.290504,"eighty":-5.995352,"marketCap":230907406},{"date":"2025-08-01","current":-10.3123,"twenty":-11.417996,"median":-8.322309,"eighty":-5.999887,"marketCap":207906280},{"date":"2025-08-08","current":-7.117812,"twenty":-11.413115,"median":-8.317646,"eighty":-6.007187,"marketCap":157068752},{"date":"2025-08-15","current":-7.417752,"twenty":-11.397816,"median":-8.284795,"eighty":-6.031937,"marketCap":163687532},{"date":"2025-08-22","current":-7.313926,"twenty":-11.38502,"median":-8.248313,"eighty":-6.051384,"marketCap":161396416},{"date":"2025-08-29","current":-7.533114,"twenty":-11.352391,"median":-8.20553,"eighty":-6.07083,"marketCap":166233217},{"date":"2025-09-05","current":-7.521577,"twenty":-11.328906,"median":-8.16619,"eighty":-6.082184,"marketCap":165978648},{"date":"2025-09-12","current":-7.510041,"twenty":-11.324344,"median":-8.102137,"eighty":-6.085977,"marketCap":165724080},{"date":"2025-09-19","current":-7.383143,"twenty":-11.32308,"median":-8.029147,"eighty":-6.096193,"marketCap":162923827},{"date":"2025-09-26","current":-6.864016,"twenty":-11.306938,"median":-7.99534,"eighty":-6.117091,"marketCap":151468245},{"date":"2025-10-03","current":-7.00245,"twenty":-11.284461,"median":-7.978803,"eighty":-6.13607,"marketCap":154523067},{"date":"2025-10-10","current":-6.933233,"twenty":-11.273902,"median":-7.941649,"eighty":-6.14394,"marketCap":152995656},{"date":"2025-10-17","current":-7.025522,"twenty":-11.254029,"median":-7.919223,"eighty":-6.152536,"marketCap":155032204},{"date":"2025-10-24","current":-6.933233,"twenty":-11.238912,"median":-7.886612,"eighty":-6.15364,"marketCap":152995656},{"date":"2025-10-31","current":-7.660011,"twenty":-11.221863,"median":-7.867109,"eighty":-6.157055,"marketCap":169033470},{"date":"2025-11-07","current":-5.723379,"twenty":-11.207233,"median":-7.846568,"eighty":-6.152536,"marketCap":145236460},{"date":"2025-11-14","current":-5.975732,"twenty":-11.203923,"median":-7.810247,"eighty":-6.130076,"marketCap":151640184},{"date":"2025-11-21","current":-5.935356,"twenty":-11.196876,"median":-7.805374,"eighty":-6.106084,"marketCap":150615588},{"date":"2025-11-28","current":-6.298745,"twenty":-11.189497,"median":-7.789134,"eighty":-6.105794,"marketCap":159836951},{"date":"2025-12-05","current":-6.808499,"twenty":-11.185688,"median":-7.751005,"eighty":-6.09309,"marketCap":172772473},{"date":"2025-12-12","current":-7.65136,"twenty":-11.180364,"median":-7.740764,"eighty":-6.105794,"marketCap":194160911},{"date":"2025-12-19","current":-8.055126,"twenty":-11.17075,"median":-7.739645,"eighty":-6.108975,"marketCap":204406870},{"date":"2025-12-26","current":-7.782584,"twenty":-11.167117,"median":-7.744393,"eighty":-6.11705,"marketCap":197490848},{"date":"2026-01-02","current":-7.621078,"twenty":-11.15718,"median":-7.744393,"eighty":-6.125125,"marketCap":193392464},{"date":"2026-01-09","current":-8.933316,"twenty":-11.152293,"median":-7.756452,"eighty":-6.133007,"marketCap":226691829},{"date":"2026-01-16","current":-8.610304,"twenty":-11.14373,"median":-7.77249,"eighty":-6.136686,"marketCap":218495062},{"date":"2026-01-23","current":-8.842469,"twenty":-11.14,"median":-7.785859,"eighty":-6.137239,"marketCap":224386488},{"date":"2026-01-30","current":-8.600209,"twenty":-11.137297,"median":-7.805374,"eighty":-6.137975,"marketCap":218238913},{"date":"2026-02-06","current":-8.489174,"twenty":-11.094623,"median":-7.810247,"eighty":-6.143786,"marketCap":215421275},{"date":"2026-02-13","current":-8.816541,"twenty":-11.04835,"median":-7.82296,"eighty":-6.150224,"marketCap":233126977},{"date":"2026-02-19","current":-8.646221,"twenty":-11.035063,"median":-7.849906,"eighty":-6.152344,"marketCap":228623388}],"updateTime":1771642932256},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVCT\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2611934901","title":"Nuvectis Pharma Files $150 Million Mixed Shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2611934901","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611934901?lang=en_us&edition=fundamental","pubTime":"2026-02-14 05:30","pubTimestamp":1771018246,"startTime":"0","endTime":"0","summary":"Nuvectis Pharma  filed a shelf registration statement Friday with the US Securities and Exchange Commission for the potential sale of up to $150 million of securities from time to time.The filing covers the sale of the company's common stock, preferred stock, warrants, debt securities, and units comprising any combination of those securities.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2611936361","title":"Nuvectis Pharma files $150M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2611936361","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611936361?lang=en_us&edition=fundamental","pubTime":"2026-02-14 05:05","pubTimestamp":1771016711,"startTime":"0","endTime":"0","summary":"16:03 EST Nuvectis Pharma (NVCT) files $150M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving br...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nuvectis-pharma-files-150m-mixed-securities-shelf-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nuvectis-pharma-files-150m-mixed-securities-shelf-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2611198223","title":"Nuvectis Pharma Inc : Files for Mixed Shelf Offering of up to $150 Mln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2611198223","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611198223?lang=en_us&edition=fundamental","pubTime":"2026-02-14 05:02","pubTimestamp":1771016527,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nFWN3Z91FS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2610892955","title":"Nuvectis Pharma Q4 EPS $(0.31), Inline","url":"https://stock-news.laohu8.com/highlight/detail?id=2610892955","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610892955?lang=en_us&edition=fundamental","pubTime":"2026-02-11 22:13","pubTimestamp":1770819199,"startTime":"0","endTime":"0","summary":"Nuvectis Pharma (NASDAQ:NVCT) reported quarterly losses of $(0.31) per share which met the analyst consensus estimate. This is a 13.89 percent increase over losses of $(0.36) per share from the same period last year.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/02/50540929/nuvectis-pharma-q4-eps-0-31-inline","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVCT"],"gpt_icon":0},{"id":"2610932732","title":"Nuvectis Pharma Inc. FY25 net loss attributable to common shareholders widens to USD 28.87 million, up 52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610932732","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610932732?lang=en_us&edition=fundamental","pubTime":"2026-02-11 20:32","pubTimestamp":1770813167,"startTime":"0","endTime":"0","summary":"Nuvectis Pharma Inc. reported its financial results for the full year ended December 31, 2025. Research and development expenses for the period totaled USD 18.15 million, while general and administrative expenses amounted to USD 9.42 million. The company recorded a finance income of USD 1.13 million. Operating loss for the year was USD 27.57 million, and net loss stood at USD 26.44 million. The total net loss attributable to common shareholders was USD 28.87 million, with basic and diluted net loss per common share at USD 1.32. Shareholders' equity as of December 31, 2025, was USD 18.41 million, and total liabilities and shareholders' equity reached USD 31.71 million. During the year, Nuvectis Pharma Inc. made significant progress in its NXP900 development program. The company highlighted advancements in the Phase 1b monotherapy study of NXP900, an oral small molecule inhibitor targeting the SRC Family of Kinases, including SRC and YES1. Management noted that these developments lay the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nNDLbn2Q5c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2610932720","title":"Nuvectis Pharma, Inc. Reports 2025 Financial Results and Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2610932720","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610932720?lang=en_us&edition=fundamental","pubTime":"2026-02-11 20:30","pubTimestamp":1770813000,"startTime":"0","endTime":"0","summary":"FORT LEE, N.J., Feb.  11, 2026  (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) (\"Nuvectis\" or the \"Company\"), a clinical-stage biopharmaceutical company focused on the development of innovat","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/11/3236181/0/en/Nuvectis-Pharma-Inc-Reports-2025-Financial-Results-and-Business-Highlights.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2592994042","title":"Nuvectis Pharma Announces the Initiation of the Phase 1B Study of Nxp900 in Combination With Osimertinib in Patients With Nsclc","url":"https://stock-news.laohu8.com/highlight/detail?id=2592994042","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592994042?lang=en_us&edition=fundamental","pubTime":"2025-12-17 20:00","pubTimestamp":1765972803,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nTUADYJSQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NVCT"],"gpt_icon":0},{"id":"2592992590","title":"Nuvectis Pharma Announces the Initiation of the Phase 1b Study of NXP900 in Combination with Osimertinib in Patients with NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2592992590","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592992590?lang=en_us&edition=fundamental","pubTime":"2025-12-17 20:00","pubTimestamp":1765972800,"startTime":"0","endTime":"0","summary":"The study is designed to evaluate the safety and clinical activity of NXP900 in combination with osimertinib in patients with epidermal growth factor receptor mutated (EGFR mut+) non-small cell lung c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/17/3206848/0/en/Nuvectis-Pharma-Announces-the-Initiation-of-the-Phase-1b-Study-of-NXP900-in-Combination-with-Osimertinib-in-Patients-with-NSCLC.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2586912473","title":"Nuvectis Pharma Hosts Virtual Meeting on NXP900 Phase 1b Program in Advanced Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2586912473","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586912473?lang=en_us&edition=fundamental","pubTime":"2025-11-25 21:00","pubTimestamp":1764075624,"startTime":"0","endTime":"0","summary":"Nuvectis Pharma Inc. will host a virtual Key Opinion Leader Meeting on Tuesday, December 2, 2025, at 8:00 AM ET to discuss the NXP900 Phase 1b Program in advanced solid tumors, including its combination with osimertinib in non-small cell lung cancer. The event will feature experts including Dr. Alexander Spira and Dr. Asier Uncita-Broceta, and will cover key preclinical and clinical data and development strategies for NXP900. A live Q&A session will follow, and a replay will be available on the company's website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuvectis Pharma Inc. published the original content used to generate this news brief via GlobeNewswire  on November 25, 2025, and is solely responsible for the information contain","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nNDLbF7M1Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","LU2210149790.SGD","BK4139","BK4588","BK4112","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","BK4585","NDAQ","LU2210150020.SGD","LU2095319765.USD","NVCT","IE00B64PRP62.GBP","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2584541889","title":"Buy Rating for Nuvectis Pharma’s NXP900 Driven by Promising Efficacy and Development Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2584541889","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584541889?lang=en_us&edition=fundamental","pubTime":"2025-11-19 00:55","pubTimestamp":1763484925,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Naz Rahman from Maxim Group maintained a Buy rating on Nuvectis Pharma, with a price target of $17.00. Naz Rahman h...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-for-nuvectis-pharmas-nxp900-driven-by-promising-efficacy-and-development-progress-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-for-nuvectis-pharmas-nxp900-driven-by-promising-efficacy-and-development-progress-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVCT","PRGS"],"gpt_icon":0},{"id":"2581026333","title":"Nuvectis Pharma Executives Make Bold Moves with Major Stock Purchases!","url":"https://stock-news.laohu8.com/highlight/detail?id=2581026333","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581026333?lang=en_us&edition=fundamental","pubTime":"2025-11-07 10:07","pubTimestamp":1762481264,"startTime":"0","endTime":"0","summary":"New insider activity at Nuvectis Pharma ( ($NVCT) ) has taken place on November 6, 2025. In a series of significant transactions, key figures at Nu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/nuvectis-pharma-executives-make-bold-moves-with-major-stock-purchases-insider-trading?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/nuvectis-pharma-executives-make-bold-moves-with-major-stock-purchases-insider-trading?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","NVCT"],"gpt_icon":0},{"id":"2581009353","title":"Director Matthew L. Kaplan Acquires Common Shares of Nuvectis Pharma Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2581009353","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581009353?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:01","pubTimestamp":1762434068,"startTime":"0","endTime":"0","summary":"Matthew L. Kaplan, Director of Nuvectis Pharma Inc., reported the acquisition of common shares of Nuvectis Pharma Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuvectis Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 06, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDL2BLPq4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Director Matthew L. Kaplan Acquires Common Shares of Nuvectis Pharma Inc","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2581770198","title":"Maxim Group Reaffirms Their Buy Rating on Nuvectis Pharma (NVCT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2581770198","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581770198?lang=en_us&edition=fundamental","pubTime":"2025-11-06 01:36","pubTimestamp":1762364161,"startTime":"0","endTime":"0","summary":"Maxim Group analyst Naz Rahman reiterated a Buy rating on Nuvectis Pharma yesterday and set a price target of $17.00. According to TipRanks, Rahman...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/maxim-group-reaffirms-their-buy-rating-on-nuvectis-pharma-nvct-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/maxim-group-reaffirms-their-buy-rating-on-nuvectis-pharma-nvct-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVCT"],"gpt_icon":0},{"id":"2581279711","title":"Nuvectis Pharma Reports Progress in Oncology Drug Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2581279711","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581279711?lang=en_us&edition=fundamental","pubTime":"2025-11-05 13:05","pubTimestamp":1762319124,"startTime":"0","endTime":"0","summary":"Nuvectis Pharma, Inc. ( ($NVCT) ) has released its Q3 earnings. Here is a breakdown of the information Nuvectis Pharma, Inc. presented to its inves...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nuvectis-pharma-reports-progress-in-oncology-drug-development?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nuvectis-pharma-reports-progress-in-oncology-drug-development?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065732104.USD","BK4097","NVCT","BK4139","PRGS"],"gpt_icon":0},{"id":"2580627756","title":"Analysts Offer Insights on Healthcare Companies: Alpha Teknova (TKNO) and Nuvectis Pharma (NVCT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2580627756","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580627756?lang=en_us&edition=fundamental","pubTime":"2025-11-04 23:31","pubTimestamp":1762270278,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alpha Teknova (TKNO – Research Report) and Nuvectis ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alpha-teknova-tkno-and-nuvectis-pharma-nvct-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alpha-teknova-tkno-and-nuvectis-pharma-nvct-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4585","BK4581","BK4539","XLV","XBI","TKNO","BK4139","BK4588","HCSG","LABU","BK4121","LU0029874061.USD","NVCT","BK4137"],"gpt_icon":0},{"id":"2580873298","title":"Nuvectis Pharma Q3 EPS $(0.44) Misses $(0.25) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2580873298","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580873298?lang=en_us&edition=fundamental","pubTime":"2025-11-04 21:30","pubTimestamp":1762263038,"startTime":"0","endTime":"0","summary":"Nuvectis Pharma (NASDAQ:NVCT) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0.25) by 73.91 percent. This is a 83.33 percent decrease over losses of $(0.24) per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48618467/nuvectis-pharma-q3-eps-0-44-misses-0-25-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVCT"],"gpt_icon":0},{"id":"2580734428","title":"BRIEF-Nuvectis Pharma Q3 EPS USD -0.44","url":"https://stock-news.laohu8.com/highlight/detail?id=2580734428","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580734428?lang=en_us&edition=fundamental","pubTime":"2025-11-04 21:15","pubTimestamp":1762262146,"startTime":"0","endTime":"0","summary":"BRIEF-Nuvectis Pharma Q3 EPS USD -0.44\n\n\nNov 04 (Reuters) - Nuvectis Pharma Q3 operating income USD -7.794 million.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nPLX4C862A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NVCT"],"gpt_icon":0},{"id":"2580739647","title":"Nuvectis Pharma Q3 net loss widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2580739647","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580739647?lang=en_us&edition=fundamental","pubTime":"2025-11-04 20:37","pubTimestamp":1762259856,"startTime":"0","endTime":"0","summary":"Nuvectis Pharma Q3 net loss widensOverviewNuvectis Q3 net loss widens to $7.5 mln, driven by milestone and study costsCash position improves to $35.4 mln, supported by public offering and ATM facility","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nL1N3WG0LH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NVCT"],"gpt_icon":0},{"id":"2580973986","title":"Nuvectis Pharma Inc: Cash Runway Expected to Support Company's Operations Into 3Q-2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2580973986","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580973986?lang=en_us&edition=fundamental","pubTime":"2025-11-04 20:30","pubTimestamp":1762259456,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nFWN3WG0AN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2580360017","title":"Nuvectis Pharma reports third quarter net loss of $7.5 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2580360017","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580360017?lang=en_us&edition=fundamental","pubTime":"2025-11-04 20:30","pubTimestamp":1762259427,"startTime":"0","endTime":"0","summary":"Nuvectis Pharma Inc. reported cash and cash equivalents of $35.4 million as of September 30, 2025, up from $18.5 million at the end of 2024, primarily due to a public offering in February 2025 and the use of its At-the-Market facility. The company reported a net loss of $7.5 million for the third quarter of 2025, compared to a net loss of $4.2 million for the same period in 2024. The increase in net loss was mainly attributed to a one-time $2.0 million milestone expense for NXP900, $0.7 million related to a clinical drug-drug interaction study, and $1.5 million in non-cash stock-based compensation. Key business developments included the initiation of the NXP900 Phase 1b program as a single agent, completion of the Phase 1a dose escalation study, and the successful completion of a clinical drug-drug interaction study in healthy volunteers. The company expects its cash runway to support operations into the third quarter of 2027.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nNDL5rpF2Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","BK4112","IE00BGHQF748.EUR","IE00B64PRP62.GBP","IE00BKPKM429.USD","NVCT","LU0314104364.USD","LU2210150020.SGD","IE00B3QW5Z07.USD","BK4585","LU2095319765.USD","BK4588","BK4139","NDAQ"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":32,"code":"91000000","status":"200"}]}}